Abstract:Background: Gastric cancer is a common and highly lethal malignancy in the world, but its pathogenesis remains elusive. In this study, we focus on the biological functions of CDK-associated Cullin1 (CAC1), a novel gene of the cullin family, in gastric cancer, which may help us to further understand the origin of this malignancy.Methods: The AGS and MGC803 gastric cancer cell lines and the GES-1 gastric mucosa cell line were selected for study. At first, CAC1 expressions of those cell lines were examined by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and western blot examinations, then CAC1 small interfering RNA (CAC1-siRNA) were designed and transfected into the AGS cell line with a relatively high level of CAC1. Once CAC1 was silenced, a series of biological characteristics of AGS cells such as cell proliferation, cell cycle, apoptosis, and expressions of apoptosis-related genes (P53, BCL2 and BAX) were determined by MTT, flow cytometry, qRT-PCR and western blot, respectively.Results: CAC1 expression of AGS or MGC803 was much higher than that of GES-1. After CAC1 expression was effectively depressed by RNA interference in AGS cells, significant cell growth inhibition occurred. Furthermore, the proportion of cells treated with CAC1-siRNA increased in the G1 phase and decreased in the S phase, indicative of G1 cell cycle arrest. More importantly, the proportions of early/late apoptosis in AGS cells were enhanced with cis-diaminedichloroplatinum (cisplatin, CDDP) treatment, but to a higher extent with cisplatin plus CAC1-siRNA. Interestingly, BCL2 mRNA copies showed about a 30% decrease in the cisplatin group, but dropped by around 60% in the cisplatin plus CAC1-siRNA group. Conversely, the P53 mRNA expressions obtained nearly a two-fold increase in the cisplatin group, in addition to a five-fold increase in the cisplatin plus CAC1-siRNA group, and the BAX mRNA levels had almost a two- and four-fold augmentation, respectively. Meanwhile, P53, BAX and BCL2 showed the same alteration patterns in western blot examinations.Conclusions: CAC1 can promote cell proliferation in the AGS gastric cancer cell line. Moreover, it can prevent AGS cells from experiencing cisplatin-induced apoptosis via modulating expressions of P53, BCL2 and BAX.

Transfection of PDCD5 Effect on the Biological Behavior of Tumor Cells and Sensitized Gastric Cancer Cells to Cisplatin-Induced Apoptosis

Transfection of Pdcd5 Sensitizes Colorectal Cancer Cells to Cisplatin-Induced Apoptosis in Vitro and in Vivo

Programmed cell death 5 enhance inhibitory effect of cisplatin on growth of colorectal carcinoma cells in vivo

PDCD5 Promotes Cisplatin-Induced Apoptosis of Glioma Cells Via Activating Mitochondrial Apoptotic Pathway

Expression of Programmed Cell Death 5 Gene Involves in Regulation of Apoptosis in Gastric Tumor Cells

Recombinant Human PDCD5 Protein Enhances Chemosensitivity of Breast Cancer in Vitro and in Vivo.

Effect of recombinant human programmed cell death 5 protein on cell apoptosis of human bladder cancer cell line BIU87 induced by cisplatin and its mechanism

The Interaction Between PDCD4 and YB1 is Critical for Cervical Cancer Stemness and Cisplatin Resistance.

Recombinant Human PDCD5 Sensitizes Chondrosarcomas to Cisplatin Chemotherapy in Vitro and in Vivo

CDK-associated Cullin 1 Can Promote Cell Proliferation and Inhibit Cisplatin-Induced Apoptosis in the AGS Gastric Cancer Cell Line

1,25-Dihydroxyvitamin D3 and Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest in Gastric Cancer Cells

The Clinical Significance of Reduced Programmed Cell Death 5 Expression in Human Gastrointestinal Stromal Tumors.

Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis

The roles of serum PDCD5 in circulating CD133 positive cells of the patients with gastric cancer

Apoptosis-inducing effect of the DR5 monoclonal antibody, D-6, alone or in combination with cisplatin, on A2780 ovarian cancer cells.

Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer

Cisplatin augments apoptosis of esophageal carcinoma cells induced by agonistic anti-hDR5 antibody by DR5 and mitochondria death pathway

Recombinant Human PDCD5 Protein Enhances Chemosensitivities of Hematologic Malignancies

Programmed Cell Death 4 Enhances Chemosensitivity Of Ovarian Cancer Cells By Activating Death Receptor Pathway In Vitro And In Vivo

Sensitizing effect of recombinant human PDCD5 protein on chemotherapy of acute monocytic leukemia cell line U937 and its mechanism]

Tumoricidal activity of combining the agonistic DR5 antibody D-6 with cisplatin in C30 cisplatin-resistant ovarian cancer in vitro and in vivo.